SCHEMBL2168809

SCHEMBL2168809

NCCc1cccc(N)c1

nearest known ligand 0.72

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.72
MAOA P21397 2/20 0.68
MAOB P27338 2/20 0.68
TAAR1 Q96RJ0 8/20 0.59
DRD2 P14416 1/20 0.59
DRD1 P21728 1/20 0.59
HTR2A P28223 2/20 0.54
CYP2A6 P11509 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
LOXL2 Q9Y4K0 1/20 0.54
HTR6 P50406 2/20 0.52
HTR2C P28335 1/20 0.52
CYP3A4 P08684 1/20 0.50
CASP1 P29466 1/20 0.50
RECQL P46063 1/20 0.50
NOS1 P29475 1/20 0.48
HTR7 P34969 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29554565 1.00 CYP19A1 (0.72) CYP19A1MAOAMAOBTAAR1DRD2
Hydrochloric Acid SCHEMBL25170417 0.98 MAOA (0.69) CYP19A1MAOAMAOBTAAR1DRD2
Hydrochloric Acid SCHEMBL28745000 0.98 MAOA (0.69) CYP19A1MAOAMAOBTAAR1DRD2
Hydrochloric Acid SCHEMBL31053748 0.98 MAOA (0.69) CYP19A1MAOAMAOBTAAR1DRD2
SCHEMBL2154372 0.87 MAOB (0.86) CYP19A1MAOAMAOBSMN1; SMN2CYP3A4
SCHEMBL29436994 0.87 MAOB (0.86) CYP19A1MAOAMAOBSMN1; SMN2CYP3A4
SCHEMBL951868 0.86 MAOA (0.63) CYP19A1MAOAMAOBTAAR1DRD2
SCHEMBL659100 0.85 TAAR1 (0.70) CYP19A1TAAR1DRD2DRD1HTR2A
SCHEMBL8971462 0.85 MAOB (0.61) CYP19A1MAOAMAOBTAAR1DRD2
Hydrochloric Acid SCHEMBL25231681 0.85 MAOA (0.64) CYP19A1MAOAMAOBTAAR1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117586481-A Method for preparing epoxy resin 浙江大学 2024-02-23 CN claimed
EP-1809684-B1 METHODS OF PRODUCING AMINE-TERMINATED CAPROLACTONE POLYMERS AND USES OF THE PRODUCED POLYMERS SOLVAY (BE) 2008-03-05 EP claimed
CN-122094914-A Zeolite, resin composition, liquid sealing agent, underfill material, method for producing sealing material, and electronic device 2026-05-26 CN disclosed
US-20260035513-A1 RESIN COMPOSITION, REINFORCED COMPOSITE MATERIAL, SHAPED PRODUCT, AND METHOD OF RECOVERING REINFORCING FIBER FROM REINFORCED COMPOSITE MATERIAL ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-02-05 US disclosed
US-20250382418-A1 DISPLAY PANEL, ALIGNMENT FILM COMPOSITION AND DISPLAY DEVICE Guangzhou China Star Optoelectronics Semiconductor Display Technology Co., Ltd. (CN) 2025-12-18 US disclosed
US-20250282996-A1 ALIGNMENT FILM COMPOSITION, DISPLAY PANEL AND METHOD OF MANUFACTURE THEREOF TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2025-09-11 US disclosed
EP-4578892-A1 RESIN COMPOSITION, COMPOSITE REINFORCING MATERIAL, MOLDED BODY, AND METHOD FOR RECOVERING REINFORCING FIBERS FROM COMPOSITE REINFORCING MATERIAL Asahi Kasei Kabushiki Kaisha (JP) 2025-07-02 EP disclosed
WO-2025127092-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-06-19 WO disclosed
CN-116438141-B Zeolite, method for producing zeolite, composition, liquid sealant, resin composite material, sealing material, method for producing sealing material, and apparatus 三菱化学株式会社 2025-06-10 CN disclosed
CN-119620472-A Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same 日产化学株式会社 2025-03-14 CN disclosed
CN-119343635-A Protective film for drug resistance 日产化学株式会社 2025-01-21 CN disclosed
WO-2001023365-A1 QUINAZOLINONES MERCK PATENT GMBH (DE) 2001-04-05 WO disclosed
EP-1070711-A2 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses Sankyo Company Limited (JP) 2001-01-24 EP disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed
US-5792840-A SUBSTITUTED GLUCOPYRANOSYL PHOSPHATES SANKYO COMPANY, LIMITED (JP) 1998-08-11 US disclosed
EP-0437016-B1 Lipid A analogues having immunoactivating and anti-tumour activity SANKYO CO (JP) 1996-05-01 EP disclosed
EP-0437016-A2 Lipid A analogues having immunoactivating and anti-tumour activity Sankyo Company Limited (JP) 1991-07-17 EP disclosed
EP-0167288-A2 4-(2-(N,N-disubstituted-amino)ethyl]isatins SMITHKLINE BEECHAM CORPORATION (US) 1986-01-08 EP disclosed
EP-0027906-B1 PROCESS FOR PREPARING SULPHON AMIDES BAYER AG (DE) 1983-05-25 EP disclosed
EP-0027906-A1 Process for preparing sulphon amides BAYER AG (DE) 1981-05-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035513-A1 RESIN COMPOSITION, REINFORCED COMPOSITE MATERIAL, SHAPED PRODUCT, AND METHOD OF RECOVERING REINFORCING FIBER FROM REINFORCED COMPOSITE MATERIAL TAF1, TAF1L, TAF9 CYP19A1 4426/4885MAOA 1110/4885MAOB 2358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.